Sarclisa 500 mg/25 mL (20 mg/mL) injection Images

Generic Name: isatuximab

This medication has been identified as Sarclisa 500 mg/25 mL (20 mg/mL) injection. It is supplied by Sanofi.

Sarclisa is used in the treatment of Multiple Myeloma and belongs to the drug class CD38 monoclonal antibodies. Sarclisa 500 mg/25 mL (20 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Sarclisa

Generic Name

isatuximab

Strength

500 mg/25 mL (20 mg/mL) injection

Availability

Prescription only

Drug Class

CD38 monoclonal antibodies

CSA Schedule

Not a controlled drug

Labeler / Supplier

Sanofi

National Drug Code (NDC)

00024-0656

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer